Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07383688 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neuspera Revision Registry - Follow up Revision Experience and Evaluation of Device Outcomes Metrics

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Oct 2026 → Apr 2027
Primary endpoint reworded 1 of 1 changed
See other at-risk trials from Neuspera Medical, Inc.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoint(s) modified Show 6 more changesShow less
    • Recruitment opened
    • Primary and study completion pushed from Oct 2026 to Apr 2027
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 2026 to Apr 1, 2026
    • Eligibility criteria expanded, about 7 words
    • Study title expanded, about 1 word
  2. Enrollment target: 20 to 100
    • Primary and study completion dates: Sep 2026 to Oct 2026
    • Start date: Feb 2026 to Mar 2026
    • Study title expanded, about 9 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Single-arm study where subjects' responses to a questionnaire for the traditional Sacral Neuromodulation (SNM) devices will be compared to the responses regarding the Neuspera SNM System.
Trial Details
NCT Number NCT07383688
Lead Sponsor Neuspera Medical, Inc.
Conditions
(from sponsor)		 Urinary Urge Incontinence
Related terms Urinary Incontinence, Urge
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov